We visualized DNA topoisomerases in A431 cells and isolated chromosomes by isoenzyme-selective immunofluorescence microscopy. In interphase, topoisomerase I mainly had a homogeneous nuclear distribution. 10–15% of the cells exhibited granular patterns, 30% showed bright intranucleolar patches. Topoisomerase II isoenzymes showed spotted (α) or reticular (β) nuclear patterns throughout interphase. In contrast to topoisomerase IIα, topoisomerase IIβ was completely excluded from nucleoli. In mitosis, topoisomerase IIβ diffused completely into the cytosol, whereas topoisomerases I and IIα remained chromosome bound. Chromosomal staining of topoisomerase I was homogeneous, whereas topoisomerase IIα accumulated in the long axes of the chromosome arms and in the centriols. Topoisomerase antigens were 2–3-fold higher in mitosis than in interphase, but specific activities of topoisomerase I and II were reduced 5- and 2.4-fold, respectively. These changes were associated with mitotic enzyme hyperphosphorylation. In interphase, topoisomerases could be completely linked to DNA by etoposide or camptothecin, whereas in mitosis, 50% of topoisomerase IIα escaped poisoning. Refractoriness to etoposide could be assigned to the salt-stable scaffold fraction of topoisomerase IIα, which increased from <2% in G1 phase to 48% in mitosis. Topoisomerases I and IIβ remained completely extractable throughout the cell cycle. In summary, expression of topoisomerases increases towards mitosis, but specific activities decrease. Topoisomerase IIβ is released from the heterochromatin, whereas topoisomerase I and IIα remain chromosome bound. Scaffold-associated topoisomerase IIα appears not to be involved in catalytic DNA turnover, though it may play a role in the replicational cycle of centriols, where it accumulates during M phase.
Skip Nav Destination
Article navigation
24 February 1997
Article Contents
Article|
February 24 1997
Cell Cycle–coupled Relocation of Types I and II Topoisomerases and Modulation of Catalytic Enzyme Activities
Kay N. Meyer,
Kay N. Meyer
*Medizinische Poliklinik and ‡Institute of Pathology, University of Würzburg, Germany; §Department of Human Genetics and ‖Department of Molecular and Structural Biology, University of Aarhus, Denmark; ¶Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom; and **Laboratory of Medical Mycology, Institute for Disease Mechanism and Control, Nagoya University, Japan
Search for other works by this author on:
Eigil Kjeldsen,
Eigil Kjeldsen
*Medizinische Poliklinik and ‡Institute of Pathology, University of Würzburg, Germany; §Department of Human Genetics and ‖Department of Molecular and Structural Biology, University of Aarhus, Denmark; ¶Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom; and **Laboratory of Medical Mycology, Institute for Disease Mechanism and Control, Nagoya University, Japan
Search for other works by this author on:
Tobias Straub,
Tobias Straub
*Medizinische Poliklinik and ‡Institute of Pathology, University of Würzburg, Germany; §Department of Human Genetics and ‖Department of Molecular and Structural Biology, University of Aarhus, Denmark; ¶Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom; and **Laboratory of Medical Mycology, Institute for Disease Mechanism and Control, Nagoya University, Japan
Search for other works by this author on:
Birgitta R. Knudsen,
Birgitta R. Knudsen
*Medizinische Poliklinik and ‡Institute of Pathology, University of Würzburg, Germany; §Department of Human Genetics and ‖Department of Molecular and Structural Biology, University of Aarhus, Denmark; ¶Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom; and **Laboratory of Medical Mycology, Institute for Disease Mechanism and Control, Nagoya University, Japan
Search for other works by this author on:
Ian D. Hickson,
Ian D. Hickson
*Medizinische Poliklinik and ‡Institute of Pathology, University of Würzburg, Germany; §Department of Human Genetics and ‖Department of Molecular and Structural Biology, University of Aarhus, Denmark; ¶Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom; and **Laboratory of Medical Mycology, Institute for Disease Mechanism and Control, Nagoya University, Japan
Search for other works by this author on:
Akihiko Kikuchi,
Akihiko Kikuchi
*Medizinische Poliklinik and ‡Institute of Pathology, University of Würzburg, Germany; §Department of Human Genetics and ‖Department of Molecular and Structural Biology, University of Aarhus, Denmark; ¶Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom; and **Laboratory of Medical Mycology, Institute for Disease Mechanism and Control, Nagoya University, Japan
Search for other works by this author on:
Hans Kreipe,
Hans Kreipe
*Medizinische Poliklinik and ‡Institute of Pathology, University of Würzburg, Germany; §Department of Human Genetics and ‖Department of Molecular and Structural Biology, University of Aarhus, Denmark; ¶Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom; and **Laboratory of Medical Mycology, Institute for Disease Mechanism and Control, Nagoya University, Japan
Search for other works by this author on:
Fritz Boege
Fritz Boege
*Medizinische Poliklinik and ‡Institute of Pathology, University of Würzburg, Germany; §Department of Human Genetics and ‖Department of Molecular and Structural Biology, University of Aarhus, Denmark; ¶Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom; and **Laboratory of Medical Mycology, Institute for Disease Mechanism and Control, Nagoya University, Japan
Search for other works by this author on:
Kay N. Meyer
,
Eigil Kjeldsen
,
Tobias Straub
,
Birgitta R. Knudsen
,
Ian D. Hickson
,
Akihiko Kikuchi
,
Hans Kreipe
,
Fritz Boege
*Medizinische Poliklinik and ‡Institute of Pathology, University of Würzburg, Germany; §Department of Human Genetics and ‖Department of Molecular and Structural Biology, University of Aarhus, Denmark; ¶Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom; and **Laboratory of Medical Mycology, Institute for Disease Mechanism and Control, Nagoya University, Japan
K. Meyer and E. Kjeldsen contributed equally to this publication.
Purified recombinant human topoisomerase IIβ was kindly provided by Dr. Ole Westergaard (Department of Structural and Molecular Biology, University of Aarhus, Denmark). We would also like to thank Dr. Westergaard for helpful discussions. We are grateful to Ms. Berit Hornstrup for helping us prepare the manuscript.
Received:
July 22 1996
Revision Received:
October 15 1996
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1997
J Cell Biol (1997) 136 (4): 775–788.
Article history
Received:
July 22 1996
Revision Received:
October 15 1996
Citation
Kay N. Meyer, Eigil Kjeldsen, Tobias Straub, Birgitta R. Knudsen, Ian D. Hickson, Akihiko Kikuchi, Hans Kreipe, Fritz Boege; Cell Cycle–coupled Relocation of Types I and II Topoisomerases and Modulation of Catalytic Enzyme Activities. J Cell Biol 24 February 1997; 136 (4): 775–788. doi: https://doi.org/10.1083/jcb.136.4.775
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
